- Home
- EBS vs VREX Comparison
EBS vs VREX Comparison
Compare EBS & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- VREX
- Stock Information
- Founded
- EBS 1998
- VREX 2016
- Country
- EBS United States
- VREX United States
- Employees
- EBS N/A
- VREX N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- VREX Industrial Machinery/Components
- Sector
- EBS Health Care
- VREX Technology
- Exchange
- EBS Nasdaq
- VREX Nasdaq
- Market Cap
- EBS 393.9M
- VREX 327.1M
- IPO Year
- EBS 2006
- VREX N/A
- Fundamental
- Price
- EBS $6.34
- VREX $8.24
- Analyst Decision
- EBS Strong Buy
- VREX Strong Buy
- Analyst Count
- EBS 3
- VREX 2
- Target Price
- EBS $14.33
- VREX $22.50
- AVG Volume (30 Days)
- EBS 1.4M
- VREX 509.1K
- Earning Date
- EBS 05-07-2025
- VREX 05-08-2025
- Dividend Yield
- EBS N/A
- VREX N/A
- EPS Growth
- EBS N/A
- VREX N/A
- EPS
- EBS N/A
- VREX N/A
- Revenue
- EBS $965,400,000.00
- VREX $827,500,000.00
- Revenue This Year
- EBS N/A
- VREX $1.78
- Revenue Next Year
- EBS $16.07
- VREX $4.50
- P/E Ratio
- EBS N/A
- VREX N/A
- Revenue Growth
- EBS N/A
- VREX N/A
- 52 Week Low
- EBS $4.02
- VREX $6.76
- 52 Week High
- EBS $15.10
- VREX $16.93
- Technical
- Relative Strength Index (RSI)
- EBS 55.56
- VREX 48.47
- Support Level
- EBS $6.20
- VREX $7.48
- Resistance Level
- EBS $6.68
- VREX $8.10
- Average True Range (ATR)
- EBS 0.38
- VREX 0.38
- MACD
- EBS -0.03
- VREX 0.09
- Stochastic Oscillator
- EBS 59.94
- VREX 71.00
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.